SAN DIEGO, July 10, 2019 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced the launch of
the Pulse™ integrated technology platform. Pulse is the first,
single platform to include multiple technologies designed to help
surgeons adopt more efficient, less disruptive surgical approaches
in all spine procedures. Engineered to improve workflow, reduce
variability and increase surgical reproducibility, Pulse addresses
a broader range of clinical challenges in the operating room (OR)
compared to any other enabling technology in the spine market.
Experience the interactive Multichannel News Release here:
https://www.multivu.com/players/English/8547351-nuvasive-pulse-integrated-technology-spine-surgery/
The Pulse platform combines neuromonitoring, surgical planning,
rod bending, radiation reduction, imaging and navigation functions,
with extensible capabilities to enable increased surgical
efficiencies in the OR. These integrated technologies are designed
to improve a surgeon's ability to utilize minimally invasive
surgery (MIS) techniques, which have been shown to reduce blood
loss, hospital stays and result in less operative morbidity
compared to open spine surgery.
"NuVasive's Pulse platform provides an unmatched surgical
experience due to its responsive and optimized workflow features,"
said Juan Uribe, MD, chief of the
division of spinal disorders at Barrow Neurological Institute in
Arizona. "The benefits of the
advanced navigation and imaging, coupled with neuromontoring, allow
for optimized outcomes for patients, while gaining impactful
efficiencies for my OR staff and hospital system."
NuVasive completed limited clinical release testing of the Pulse
platform, providing initial validation that its structural design
supports broad clinical utility throughout the entire surgery, and
is useable in 100 percent of spine surgeries, from fusions to
complex corrections. Its independent device access allows OR staff
to simultaneously view the technologies' imaging and insights in
real time and in parallel, creating a seamless, optimized OR
workflow. In addition, the open and modular architecture of the
Pulse system allows for flexible technology packages, allowing
surgeons to select the exact tools they need to address specific
pathologies in spine surgery procedures.
"The Pulse platform is uniquely engineered to equip surgeons
with a single platform of integrated technologies necessary to
perform all spine surgeries, including minimally invasive
approaches," said J. Christopher
Barry, chief executive officer of NuVasive. "Pulse provides
an intuitive surgeon experience by anticipating user needs and
fusing these technologies to create a seamless, optimized OR
workflow, while addressing a broad range of clinical challenges.
This is a pivotal step in our strategic vision to deliver
end-to-end solutions that enable predictable clinical and economic
outcomes in spine surgery."
Pulse Platform Hardware and Software Modules
The Pulse platform includes the following enabling technologies,
with a modular architecture allowing surgeons and hospitals the
flexibility to meet their needs in all spinal cases:
- 2D- and 3D-Imaging and Navigation: Image transferring
for both 2D- and 3D-imaging that combines novel camera, array and
workflow technologies to improve line of sight, ease of use and
surgical efficiency in the OR. Through NuVasive's Spine Precision
Partnership™ with Siemens Healthineers, Pulse leverages the Cios
Spin cutting-edge 3D mobile C-arm.
- Surgical Planning with Integrated Global
Alignment® (iGA®): Preoperative planning software that
incorporates alignment parameters, implant integration, surgical
modeling and other tools to help create a reliable plan prior to
stepping into the OR. iGA is the only system on the market
able to intraoperatively assess the surgical approach and effects
on spinal alignment through real-time insights.
- Neuromonitoring: Automated nerve detection system with
standardized setup and clinically validated alerts that help reduce
variability and allow for faster interpretation of neural
information.
- Smart Imaging with Radiation Reduction through
LessRay®: Imaging system designed to take low-quality,
low-dose images and improve them to look like conventional
full-dose images. LessRay significantly reduces exposure to
radiation for everyone in the OR by as much as 80 percent compared
to standard fluroscopy.1
- Rod Bending with
Bendini®: Spinal rod-bending technology used to create
patient-specific rods, which are bent exactly to implant locations,
expediting manual rod manipulation through computer-assisted bend
instructions without leaving the OR.
The Pulse platform features extensible capabilities for robotics
and smart tools and the Company plans to unveil its spine robotics
module at the North American Spine Society 2019 Annual Meeting in
September.
About NuVasive
NuVasive, Inc. (NASDAQ:
NUVA) is the leader in spine technology innovation, focused on
transforming spine surgery and beyond with minimally disruptive,
procedurally integrated solutions designed to deliver reproducible
and clinically proven surgical outcomes. The Company's portfolio
includes access instruments, implantable hardware, biologics,
software systems for surgical planning, navigation and imaging
solutions, magnetically adjustable implant systems for spine and
orthopedics, and intraoperative monitoring service offerings. With
more than $1 billion in revenues,
NuVasive has approximately 2,600 employees and operates in more
than 50 countries serving surgeons, hospitals and patients. For
more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could cause NuVasive's
results to differ materially from historical results or those
expressed or implied by such forward-looking statements. The
potential risks and uncertainties which contribute to the uncertain
nature of these statements include, among others, risks associated
with acceptance of the Company's surgical products and procedures
by spine surgeons, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products (including the
iGA platform), the Company's ability to effectually manage
inventory as it continues to release new products, its ability to
recruit and retain management and key personnel, and the other
risks and uncertainties described in NuVasive's news releases and
periodic filings with the Securities and Exchange Commission.
NuVasive's public filings with the Securities and Exchange
Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
1 Wang TY, Farber SH, Perkins SS, et. al. Internally
randomized control trial of radiation exposure using ultra-low
radiation imaging versus traditional C-arm fluoroscopy for patients
undergoing single-level minimally invasive transforaminal lumbar
interbody
fusion. Spine 2017;42(4);217-23.
View original
content:http://www.prnewswire.com/news-releases/nuvasive-launches-pulse-the-first-integrated-technology-platform-to-enable-better-spine-surgery-300882385.html
SOURCE NuVasive, Inc.